Paper39119424
Chemotherapy Release From Bortezomib-Impregnated Polymethylmethacrylate-Coated Intramedullary Nails: A Novel In Vitro Study for a Local Chemotherapy Delivery Device.
Ren E and 4 others. Cureus, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Chemotherapy Release From Bortezomib-Impregnated Polymethylmethacrylate-Coated Intramedullary Nails: A Novel In Vitro Study for a Local Chemotherapy Delivery Device. Papers, record 39119424. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39119424
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemotherapy Release From Bortezomib-Impregnated Polymethylmethacrylate-Coated Intramedullary Nails: A Novel In Vitro Study for a Local Chemotherapy Delivery Device.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31628729 | Ambient theatre temperature and cement setting time in total knee arthroplasty. | ANZ J Surg | 2019 | https://conductscience.org/library/papers/31628729 | PubMed |
| 2 | 38155732 | Antibiotic cement nails manufactured with threaded rods or cannulated intramedullary nails are better than those made with guidewires and do not debond. | OTA Int | 2024 | https://conductscience.org/library/papers/38155732 | PubMed |
| 3 | 37206489 | Chemotherapy May Obviate Prophylactic Femoral Nail Surgery for Multiple Myeloma Patients With High Mirels' Score Lesions and Impending Pathological Hip Fracture. | Cureus | 2023 | https://conductscience.org/library/papers/37206489 | PubMed |
| 4 | 11485895 | New insights into the role of nuclear factor-kappaB in cell growth regulation. | Am J Pathol | 2001 | https://conductscience.org/library/papers/11485895 | PubMed |
| 5 | 21507715 | Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. | Lancet Oncol | 2011 | https://conductscience.org/library/papers/21507715 | PubMed |
| 6 | 28089230 | Metastatic fractures of long limb bones. | Orthop Traumatol Surg Res | 2017 | https://conductscience.org/library/papers/28089230 | PubMed |
| 7 | 24291039 | The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. | Toxicol Lett | 2014 | https://conductscience.org/library/papers/24291039 | PubMed |
| 8 | 27917682 | The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma. | Expert Opin Drug Discov | 2017 | https://conductscience.org/library/papers/27917682 | PubMed |
| 9 | 34401932 | A pituitary cup biopsy is more accurate than reamings for histological diagnosis of intramedullary lesions during nailing of impending and pathologic fractures: a retrospective matched cohort analysis. | Int Orthop | 2021 | https://conductscience.org/library/papers/34401932 | PubMed |
| 10 | 28556562 | Drug Release as a function of bioactivity, incubation regime, liquid, and initial load: Release of bortezomib from calcium phosphate-containing silica/collagen xerogels. | J Biomed Mater Res B Appl Biomater | 2018 | https://conductscience.org/library/papers/28556562 | PubMed |
| 11 | 24781451 | Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site. | J Oncol Pharm Pract | 2015 | https://conductscience.org/library/papers/24781451 | PubMed |
| 12 | 20435880 | Polymethylmethacrylate: properties and contemporary uses in orthopaedics. | J Am Acad Orthop Surg | 2010 | https://conductscience.org/library/papers/20435880 | PubMed |
| 13 | 33361554 | A distinctive release profile of vancomycin and tobramycin from a new and injectable polymeric dicalcium phosphate dehydrate cement (P-DCPD). | Biomed Mater | 2021 | https://conductscience.org/library/papers/33361554 | PubMed |
| 14 | 24433088 | Management of bone disease in multiple myeloma. | Expert Rev Hematol | 2014 | https://conductscience.org/library/papers/24433088 | PubMed |
| 15 | 36518066 | Antibiotic Cement-Coated Interlocked Intramedullary Nails for the Treatment of Infected Nonunion After Intramedullary Nailing. | J Orthop Trauma | 2023 | https://conductscience.org/library/papers/36518066 | PubMed |
| 16 | 23822887 | Targeting the ubiquitin-proteasome system for cancer therapy. | Expert Opin Ther Targets | 2013 | https://conductscience.org/library/papers/23822887 | PubMed |
| 17 | 25683996 | Surgical treatment of pathological fractures occurring at the proximal femur. | Yonsei Med J | 2015 | https://conductscience.org/library/papers/25683996 | PubMed |
| 18 | 27804017 | Is It Appropriate to Treat Sarcoma Metastases With Intramedullary Nailing? | Clin Orthop Relat Res | 2017 | https://conductscience.org/library/papers/27804017 | PubMed |
| 19 | 28135373 | Elution Profiles of Two Methods of Antibiotic Tibial Nail Preparations. | Orthopedics | 2017 | https://conductscience.org/library/papers/28135373 | PubMed |
| 20 | 19390905 | Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity. | Clin Orthop Relat Res | 2009 | https://conductscience.org/library/papers/19390905 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40550922 | Comparative evaluation of treatment strategies for femoral metastases: endoprosthesis reconstruction versus intramedullary nailing. | Eur J Orthop Surg Traumatol | 2025 | https://conductscience.org/library/papers/40550922 | PubMed |
| 39695697 | Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma. | J Hematol Oncol | 2024 | https://conductscience.org/library/papers/39695697 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39119424
GET https://conductscience.org/api/papers/v1/39119424/references?page=2